The CCK tetrapeptide fragment CCK-4 (Trp-Met-Asp-Phe-NH) reliably causes anxiety and panic attacks (panicogenic effect) when administered to humans and is commonly used in scientific research for this purpose of in order to test new anxiolytic drugs.